PlainRecalls
FDA Drug Critical Class I Terminated

STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC 0053-6871-00

Reported: August 26, 2020 Initiated: July 21, 2020 #D-1506-2020

Product Description

STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC 0053-6871-00

Reason for Recall

Superpotent Drug

Details

Units Affected
29,371 nasal sprays
Distribution
Nationwide within the United States.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
STIMATE (desmopressin acetate) Nasal Spray1.5 mg/mL, 2.5 mL glass vial with spray cap, Rx only, Manufactured for: CSL Behring LLC, King of Prussia, PA 19406-0901; By: Ferring GmbH, Kiel, Germany, NDC 0053-6871-00. Recalled by Ferring Pharmaceuticals Inc. Units affected: 29,371 nasal sprays.
Why was this product recalled?
Superpotent Drug
Which agency issued this recall?
This recall was issued by the FDA Drug on August 26, 2020. Severity: Critical. Recall number: D-1506-2020.